Alterity Therapeutics on Track to Complete Phase Two Trial of Lead Drug Candidate in November
Alterity Therapeutics on Track to Complete Phase Two Trial of Lead Drug Candidate in November
Alterity Therapeutics有望在11月完成主要候选药物的二期试验
Unity Software(U.US) reported fourth-quarter financial results after the market close on Monday. Here's a rundown of the report.Q4 Earnings: Unity said fourth-quarter revenue increased 35% year-over-year to $609 million, beating the consensus estimate of $562.71 million. The company reported a quarterly loss of 66 cents per share.
登录免费看全文
登录/注册